1. Market Research
  2. > Healthcare Market Trends
  3. > Healthcare Analysis & Statistics 2022 - Western Europe (p50)

Healthcare Analysis & Statistics 2022 - Western Europe (p50)

1471-1500 of about 9000 reports

Computed Tomography (CT) Systems - Medical Devices Pipeline Assessment, 2020

  • $ 4000
  • August 2020
  • 184 pages

Computed Tomography (CT) Systems - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Computed Tomography (CT) Systems - Medical Devices Pipeline Assessment, 2020" ...

  • California
  • Germany
  • CT Scan
  • Clinical Trial
  • Industry analysis
  • Medical Technology Density
  • Diagnostic Imaging Density

Organ Function Assays - Medical Devices Pipeline Assessment, 2020

  • $ 2500
  • August 2020
  • 56 pages

Organ Function Assays - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Organ Function Assays - Medical Devices Pipeline Assessment, 2020" provides comprehensive ...

  • France
  • Canada
  • Clinical Trial
  • In Vitro Diagnostic Reagent
  • Industry analysis
  • Medical Technology Density
  • Biologics Penetration Rate

Alphanate - Drug Insight and Market Forecast - 2030

  • $ 2750
  • August 2020
  • 80 pages

Overview “Alphanate - Drug Insight and Market Forecast – 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the ...

  • Europe
  • Japan
  • Clinical Trial
  • Hospital
  • Industry analysis
  • Health Expenditure
  • Medicine Use

Doptelet (avatrombopag)  - Drug Insight and Market Forecast - 2030

  • $ 2750
  • August 2020
  • 80 pages

Overview “Doptelet (avatrombopag)  - Drug Insight and Market Forecast – 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed ...

  • Europe
  • Japan
  • Clinical Trial
  • Digestive System Disorder
  • Industry analysis
  • Health Expenditure

Hemlibra (emicizumab-kxwh) - Drug Insight and Market Forecast - 2030

  • $ 2750
  • August 2020
  • 80 pages

Overview “Hemlibra – Drug Insight and Market Forecast—2030” report outlays comprehensive insights of the product based on routine prophylaxis to prevent or reduce the frequency of bleeding episodes ...

  • Europe
  • World
  • Protein Therapy
  • Blood Disease
  • Industry analysis
  • Health Expenditure

Lumizyme (alglucosidase alfa) - Drug Insight and Market Forecast - 2030

  • $ 2750
  • August 2020
  • 80 pages

Overview “Lumizyme (alglucosidase alfa) - Drug Insight and Market Forecast – 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed ...

  • Europe
  • Japan
  • Clinical Trial
  • Neurological Disorder
  • Industry analysis
  • Health Expenditure

Luxturna (voretigene neparvovec-rzyl) - Drug Insight and Market Forecast - 2030

  • $ 2750
  • August 2020
  • 80 pages

Overview “Luxturna (voretigene neparvovec-rzyl) - Drug Insight and Market Forecast – 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. ...

  • Europe
  • Japan
  • Gene Therapy
  • Clinical Trial
  • Industry analysis
  • Health Expenditure

Casimersen - Drug Insight and Market Forecast - 2030

  • $ 3250
  • August 2020
  • 80 pages

Overview “Casimersen - Emerging Insight and Market Forecast – 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture ...

  • Europe
  • World
  • Therapy
  • Clinical Trial
  • Industry analysis
  • Health Expenditure

Idebenone - Drug Insight and Market Forecast - 2030

  • $ 3250
  • August 2020
  • 80 pages

Overview “Idebenone - Emerging Insight and Market Forecast – 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture ...

  • Europe
  • World
  • Clinical Trial
  • Neurological Disorder
  • Industry analysis
  • Health Expenditure

Anti-Aging Market Research Report: By Product, Treatment, Demography - Global Industry Analysis and Growth Forecast to 2030

  • $ 4900
  • August 2020
  • 269 pages

Anti-Aging Market Research Report: By Product (Anti-Wrinkle, Hair Color, Ultraviolet Absorption, Anti-Stretch Mark), Treatment (Hair Restoration, Anti-Pigmentation, Adult Acne Therapy, Breast Augmentation, ...

  • World
  • Thailand
  • Plastic Surgery
  • Cosmetic Surgery
  • Industry analysis
  • Disposable Income

Amyloidosis - Pipeline Review, H2 2020

  • $ 2000
  • July 2020
  • 241 pages

Amyloidosis - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Amyloidosis - Pipeline Review, H2 2020, provides an overview of the Amyloidosis (Metabolic ...

  • World
  • Sweden
  • Therapy
  • Endocrine Disease
  • Industry analysis
  • Stem Cell Transplantation
  • Pharmaceutical Registrations

Dilated Cardiomyopathy - Pipeline Review, H2 2020

  • $ 2000
  • July 2020
  • 66 pages

Dilated Cardiomyopathy - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Dilated Cardiomyopathy - Pipeline Review, H2 2020, provides an overview of ...

  • World
  • Germany
  • Cardiovascular Disease
  • Cardiology
  • Industry analysis
  • Surgical Procedures Performed
  • Drug Approval

Lysosomal Alpha Glucosidase - Pipeline Review, H2 2020

  • $ 3500
  • July 2020
  • 76 pages

Lysosomal Alpha Glucosidase - Pipeline Review, H2 2020 Summary Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) - Lysosomal alpha-glucosidase is an enzyme encoded ...

  • World
  • Belgium
  • Neurological Disorder
  • Therapy
  • Industry analysis
  • Number Of R&D Personnel
  • Pharmaceutical Exports

Indoleamine 2,3 Dioxygenase 1 - Pipeline Review, H2 2020

  • $ 3500
  • July 2020
  • 130 pages

Indoleamine 2,3 Dioxygenase 1 - Pipeline Review, H2 2020 Summary Indoleamine 2,3 Dioxygenase 1 (Indoleamine Pyrrole 2,3 Dioxygenase 1 or IDO1 or EC 1.13.11.52) - Indoleamine 2,3 Dioxygenase 1 (Indoleamine ...

  • World
  • Jiangsu
  • Oncology
  • Pharmaceutical
  • Industry analysis
  • Pharmaceutical Registrations

Orthopedic Braces & Supports Market by Product, Distribution & Region - Global Forecast to 2025

  • $ 4950
  • July 2020
  • 363 pages

The global orthopedic braces and supports market is projected to grow at a CAGR of 5.8% during the forecast period The global orthopedic braces and supports market size is projected to reach USD 4.1 billion ...

  • APAC
  • United States
  • Orthopedic Accessory
  • Industry analysis
  • Sports Participation Rate

2024 France Transfusion Diagnostics Market: Immunohematology and NAT Testing--Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, Emerging Opportunities

  • $ 2500
  • July 2020
  • 430 pages

2024 France Transfusion Diagnostics Market: Immunohematology and NAT Testing--Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, ...

  • France
  • Diagnostics
  • Infectious Disease
  • Industry analysis

2024 France Hospital Hemostasis Diagnostics Marke: Supplier Shares and Sales Segment Forecasts

  • $ 2500
  • July 2020
  • 398 pages

2024 France Hospital Hemostasis Diagnostics Marke: Supplier Shares and Sales Segment Forecasts This new report contains 398 pages, 29 tables. The report is available by section, and can be customized ...

  • France
  • Coagulation Diagnostic
  • Industry analysis

2024 Germany Hospital Hemostasis Diagnostics Marke: Supplier Shares and Sales Segment Forecasts

  • $ 2500
  • July 2020
  • 394 pages

2024 Germany Hospital Hemostasis Diagnostics Marke: Supplier Shares and Sales Segment Forecasts This new report contains 394 pages, 28 tables. The report is available by section, and can be customized ...

  • Germany
  • Coagulation Diagnostic
  • Industry analysis

2024 Germany Transfusion Diagnostics Market: Immunohematology and NAT Testing--Supplier Shares and Strategies, Innovative Technologies, Instrumentation Review, Emerging Opportunities

  • $ 2500
  • July 2020
  • 426 pages

2024 Germany Transfusion Diagnostics Market: Immunohematology and NAT Testing--Supplier Shares and Strategies, Innovative Technologies, Instrumentation Review, Emerging Opportunities This new report ...

  • Germany
  • Diagnostics
  • Infectious Disease
  • Industry analysis

2024 France Nucleic Acid Testing/NAT Market for 100 Assays: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing

  • $ 2850
  • July 2020
  • 1125 pages

2024 France Nucleic Acid Testing/NAT Market for 100 Assays: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity ...

  • France
  • Molecular Diagnostics
  • Genetic Disorder
  • Industry analysis

2024 Germany Nucleic Acid Testing/NAT Market for 100 Assays: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing

  • $ 2850
  • July 2020
  • 1125 pages

2024 Germany Nucleic Acid Testing/NAT Market for 100 Assays: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity ...

  • Germany
  • Molecular Diagnostics
  • Genetic Disorder
  • Industry analysis

2024 France Infectious Disease Testing Market for Over 100 Tests: Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Competitive Landscape, Emerging Technologies, Instrumentation and Opportunities

  • $ 2850
  • July 2020
  • 890 pages

2024 France Infectious Disease Testing Market for Over 100 Tests: Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Competitive Landscape, Emerging Technologies, Instrumentation ...

  • France
  • Infectious Disease
  • Industry analysis

2024 Germany Infectious Disease Testing Market for Over 100 Tests: Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Competitive Landscape, Emerging Technologies, Instrumentation and Opportunities

  • $ 2850
  • July 2020
  • 983 pages

2024 Germany Infectious Disease Testing Market for Over 100 Tests: Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Competitive Landscape, Emerging Technologies, Instrumentation ...

  • Germany
  • Infectious Disease
  • Industry analysis

2024 France Hematology and Flow Cytometry Analyzers and Reagents Market: Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Competitive Landscape, Emerging Technologies, Instrumentation and Opportunities

  • $ 2500
  • July 2020
  • 250 pages

2024 France Hematology and Flow Cytometry Analyzers and Reagents Market: Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Competitive Landscape, Emerging Technologies, Instrumentation ...

  • France
  • Molecular Diagnostics
  • In Vitro Diagnostics
  • Industry analysis

2024 Germany Hematology and Flow Cytometry Analyzers and Reagents Market: Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Competitive Landscape, Emerging Technologies, Instrumentation and Opportunities

  • $ 2500
  • July 2020
  • 250 pages

2024 Germany Hematology and Flow Cytometry Analyzers and Reagents Market: Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Competitive Landscape, Emerging Technologies, Instrumentation ...

  • Germany
  • Molecular Diagnostics
  • In Vitro Diagnostics
  • Industry analysis

Overcoming Barriers to RPA Adoption During the COVID-19 Recovery Phase

  • $ 4500
  • July 2020
  • 6 pages

This IDC Market Perspective discusses the relevance of robotic process automation during the COVID-19 recovery phase. Interest in RPA continues to rise, and businesses believe the technology has a role ...

  • United Kingdom
  • Western Europe
  • Industrial Robot
  • Infectious Disease
  • Industry analysis

Acute Respiratory Distress Syndrome (ARDS) - Epidemiology Forecast - 2030

  • $ 3750
  • July 2020
  • 100 pages

‘Acute Respiratory Distress Syndrome (ARDS)—Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forecasted Acute Respiratory Distress Syndrome (ARDS) ...

  • United States
  • United Kingdom
  • Epidemiology
  • Industry analysis

Hereditary Angioedema - Epidemiology Forecast - 2030

  • $ 3750
  • July 2020
  • 100 pages

‘Hereditary Angioedema (HAE)– Epidemiology Forecast—2030’ report delivers an in-depth understanding of the Hereditary Angioedema, historical and forecasted epidemiology in the United States, EU5 ...

  • United States
  • France
  • Epidemiology
  • Industry analysis

Fragile X Syndrome (FXS) - Epidemiology Forecast - 2030

  • $ 3750
  • July 2020
  • 100 pages

‘Fragile X Syndrome (FXS)—Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forecasted Fragile X Syndrome (FXS) epidemiology in the United States, ...

  • United States
  • Spain
  • Epidemiology
  • Industry analysis

Contact Dermatitis (CD) - Epidemiology Forecast–2030

  • $ 3750
  • July 2020
  • 100 pages

‘Contact Dermatitis (CD) - Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forecasted Contact Dermatitis (CD) epidemiology in the United States, ...

  • United States
  • Spain
  • Dermatological Condition
  • Industry analysis
About 16000 reports

Download Unlimited Documents from Trusted Public Sources

View report >

Infectious Disease Demographic Impact in Germany

  • January 2022
  • 5 pages
  • Germany
  • Infectious Disease
  • Industry analysis
  • Mortality Rate

Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on